Overview

Dashboard News

ubs issues buy recommendation with no conflict of interest

UBS has initiated a Buy recommendation, with the analysis published by BOURSORAMA on 15/10/2024. BOURSORAMA acts solely as a distribution channel and does not influence the content, which is provided for informational purposes only, without any warranty. The institution maintains a conflict of interest management policy to ensure objectivity in its investment recommendations.
Boursorama
Euro UBS AG Societe Generale Batiment SA European Central Bank FRA Show more
TradFi, Market Report
09:00 15.10.2024

Finma halts approval of UBS emergency plans amid Credit Suisse integration challenges

Finma has suspended the approval of UBS's emergency plans due to necessary adjustments from the integration of Credit Suisse. The authority emphasizes the need for improvements to ensure UBS can be effectively restructured or liquidated in a crisis, while also calling for expanded legal frameworks for resolution strategies. UBS has begun addressing these requirements, asserting its capacity to manage potential crises without taxpayer intervention.
Blick
Swiss Franc United States Dollar Credit Suisse Anlagestiftung UBS SA CHE Ueli Maurer Roger Federer
TradFi, News Article
09:00 15.10.2024

unitedhealth projects lower 2025 profits amid rising medical costs and government cuts

UnitedHealth Group's 2025 profit forecast fell short of Wall Street expectations, predicting a maximum of $30 per share, below the $31.18 estimate. The company cited pressures from government-supported health insurance, rising medical costs, and payment cuts for Medicare and Medicaid plans. Shares dropped 8%, impacting rivals like Humana and CVS Health, as the insurer also adjusted its 2024 profit forecast downward due to a cyberattack's financial repercussions.
Reuters
United States Dollar UnitedHealth Group Incorporated Centene Corporation Humana Inc. CVS Health Corporation USA Andrew Witty Ann Hynes John Rex Show more
Finance & Economy, Market Report
09:00 15.10.2024

myriad genetics and flatiron health enhance access to genetic testing in oncology

Myriad Genetics has partnered with Flatiron Health to integrate its MyRisk Hereditary Cancer Test into Flatiron’s OncoEMR platform, enhancing access to genetic testing for over 4,200 providers across 800 cancer care locations in the U.S. This collaboration streamlines the ordering and results process, facilitating personalized treatment decisions and improving patient care outcomes. The integration is now available to all OncoEMR users.
GlobeNewswire News Room
Roche Group USA George Daneker Jr Stephen Speicher
Healthcare, Press Release
09:00 15.10.2024

Sogei under investigation amid bribery allegations in Italian public contracts

Sogei, the IT company controlled by Italy's Ministry of Economy, is crucial for managing taxpayer data, including electronic billing and health records. Recently, investigations into bribery and tender irregularities have implicated 32 individuals and companies linked to Sogei's contracts with various ministries. The company maintains its innocence and supports the judiciary's inquiries.
Corriere della Sera
United States Dollar Digital Value S.p.A. Olidata S.p.A. ITA Giancarlo Giorgetti Maurizio Leo
Technology & Innovation, News Article
09:00 15.10.2024

ontario invests 146 million to enhance life sciences sector and innovation

The Ontario government has launched the next phase of its life sciences strategy, investing $146 million to enhance research, innovation, and biomanufacturing. This initiative aims to create 5,000 jobs and solidify Ontario's position as a global leader in health sciences, with a focus on advancing R&D, unlocking capital, and supporting local companies. Key investments include funding for research infrastructure, lab access programs, and a new Life Sciences Scale-Up Fund to boost production capacity.
news.ontario.ca
Clinical Trials Ontario Apple Inc. CAN Doug Ford Vic Fedeli
Technology & Innovation, Press Release
09:00 15.10.2024

Clinical Care Medical Centers files for bankruptcy as Humana plans acquisition

Clinical Care Medical Centers has filed for bankruptcy, carrying up to $500 million in debt. The company, which operates over two dozen medical facilities in Florida and is owned by a major South Florida private equity firm, will see an insurance giant purchase some of its centers for $45 million.
South Florida Business Journal
Humana Inc. MIAMI MEDICAL GROUP USA
Finance & Economy, News Article
09:00 15.10.2024

italian government unveils 2025 budget plan with tax cuts and healthcare funding

The Italian government is set to approve the 2025 budget maneuver during the Council of Ministers meeting on October 15, aiming to meet EU deadlines. Key measures include a structural tax wedge cut, funding for healthcare and public administration, and across-the-board cuts to ministries to save 3 billion euros. The government seeks to raise 25 billion euros without increasing the deficit, relying on unexpected tax revenues and contributions from banks, while avoiding new taxes.
QuiFinanza
Euro Forza Italia ITA Giancarlo Giorgetti Minister Schillaci Giorgia Meloni Show more
Finance & Economy, Press Release
09:00 15.10.2024

global leaders pledge support for who amid pandemic and climate challenges

At the World Health Summit in Berlin, leaders including German Chancellor Olaf Scholz and Health Minister Karl Lauterbach emphasized the need for increased funding for the WHO to combat future pandemics and climate change, pledging hundreds of millions in support. The summit highlighted the importance of global cooperation, with calls for wealthier nations to assist poorer ones in healthcare, and discussions on a proposed global billionaires' tax to enhance financial contributions. The WHO aims to secure over $1 billion for its initiatives, reinforcing its role in international health governance.
Apollo News
United States Dollar Euro Pfizer Inc. Microsoft Corporation BRA DEU ZAF Karl Lauterbach Bill Gates Ursula von der Leyen Svenja Schulze Olaf Scholz Show more
Finance & Economy, News Article
09:00 15.10.2024

dr horton shares rise 2.44 percent amid market challenges and strong performance

DR Horton shares rose 2.44% to USD 187.23 on October 15, 2024, despite a recent monthly decline of 1.86%, showcasing a strong annual performance of 77.58%. The company plans a dividend of USD 1.20 per share, yielding 0.82%, and maintains an attractive P/E ratio of 13.09, reflecting its solid financial position amid market challenges.
aktiencheck.de
United States Dollar D.R. Horton, Inc. USA
Finance & Economy, Market Report
09:00 15.10.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Cryptocurrency & Blockchain Regulations Central Bank Actions Market Sentiment Analysis Banking & Investment Regulations Employment Reports Banking Regulations Corporate Responsibility & ESG Anti-Money Laundering (AML) Regulations Inflation Rates & CPI Data Blockchain Technology Adoption Hedge Funds & Private Equity Cryptocurrency Regulations Tokenomics and Crypto Economics Decentralized Finance (DeFi) Innovations Mergers & Acquisitions Emerging Startups Cryptocurrency Developments
Countries:
USA GBR CHE DEU RUS IND CHN CAN ARE FRA JPN SGP TWN ESP MYS BRA LUX KEN THA AUS
Companies:
Coinbase Global, Inc. Apple Inc. NVIDIA Corporation Solana USD Ethereum USD Tesla, Inc. Chainlink USD Bitwise Bitcoin ETF Fidelity Contrafund UBS Group AG BlackRock, Inc. MicroStrategy Inc Delta Air Lines, Inc. Kraken Energy Corp. Ripple USD USD Ripples USD Microsoft Corporation Standard Chartered PLC Novartis AG Bank of America Corporation
Currencies:
United States Dollar Euro Swiss Franc British Pound Sterling Japanese Yen Indian Rupee Swedish Krona Chinese Yuan Canadian Dollar Singapore Dollar South Korean Won New Taiwan Dollar Thai Baht Philippine Peso Russian Ruble Vietnamese Đồng
People:
Donald Trump Elon Musk Ali Martinez Cynthia Lummis Gary Gensler Joe Biden Paul Atkins Brad Garlinghouse Bill Hughes Sr Tim Scott Matt Hougan Jerome Powell Bernie Moreno Elizabeth Warren Laurent Marochini Margaret Harwood-jones Keith Ammon James Howells Jimmy Carter Dave McCormick

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings